Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    2.30 (2.49%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Trading Statement

7 Mar 2019 07:00

C&C Group Plc(β€œC&C” or the β€œGroup”)

Period end trading update for the 12 months ended 28 February 2019

Dublin, London | 7 March, 2019:Β Following from its trading update of 10 January, 2019, C&C today reports that Group EBIT, for the 12-month period to 28 February, 2019 (β€˜FY19’), is now expected to be towards the upper end of current market estimates and full year adjusted EPS growth is anticipated to be c.20%.

Operational delivery, customer service and the underlying cash contribution of both Matthew Clark and Bibendum in the second half have continued to improve. Consequently, Group year-end net debt is now expected to be well below current market estimates, within a range of €305m - €312m.

Matthew Clark and Bibendum have significant underlying momentum, across key financial and performance measures, with good progress made on the identification of synergy benefits. In our Scottish and Irish and branded businesses, positive trading momentum continued. The sponsorship of next week’s Cheltenham Gold Cup by our Irish cider brands, Magners and Bulmers will build on this momentum and demonstrates the ambition we have for these brands.

C&C will host a capital markets day with the announcement of its FY19 results on 22 May, 2019, at which the Group will provide its medium-term outlook together with the underlying assumptions.

ENDS

Contacts

C&C Group plcStephen Glancey | Group Chief ExecutiveJonathan Solesbury | Chief Financial OfficerJoe Thompson | Head of Investor RelationsTel: +44 7980 844 580Email: Joe.Thompson@candcgroup.com

FTI ConsultingJonathan Neilan/Paddy BerkeryTel: +353 1 765 0884Email: CandCGroup@fticonsulting.com

Novella CommunicationsTim Robertson/Toby AndrewsTel: +44 203 151 7008Email: TimR@novella-comms.com

_____________________________________________________________________________________________________________________

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

C&C Group’s portfolio of owned/exclusive brands include: Bulmers, the leading Irish cider brand; Tennent’s, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of fast-growing, super-premium and craft ciders and beers, such as Heverlee, Menabrea and Orchard Pig. C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland; Glasgow, Scotland; and Vermont, US, where it manufactures Woodchuck, a leading craft cider brand in the United States. C&C is the No.#1 drinks distributor to the UK and Ireland hospitality sectors. Operating under the Matthew Clark, Bibendum, Tennent's and C&C Gleeson brands, the Group supplies over 35,000 pubs, bars, restaurants and hotels, and is a key route-to-market for major international beverage companies. C&C Group also has a minority investment in the Admiral Taverns tenanted pub group, which owns over 800 pubs across England & Wales and exports its Magners and Tennent’s brands to over 60 countries worldwide.

C&C Group is headquartered in Dublin and is listed on the Irish and London Stock Exchanges.

Note regarding forward-looking statements

This announcement includes forward-looking statements, including statements concerning current expectations about future financial performance and economic and market conditions which C&C believes are reasonable. However, these statements are neither promises nor guarantees, but are subject to risks and uncertainties, including those factors discussed on page 16 of our Interim results for the six months ended 31 August 2018, that could cause actual results to differ materially from those anticipated.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190306005740/en/

Copyright Business Wire 2019

Date   Source Headline
15th Feb 20247:00 amRNSDirectorate Changes
2nd Feb 202410:00 amRNSTotal Voting Rights and Capital
15th Jan 20242:20 pmRNSDirector/PDMR Shareholding
4th Jan 202412:45 pmRNSTotal Voting Rights
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
12th Dec 20231:05 pmRNSHolding(s) in Company
6th Dec 20233:30 pmRNSDirectorate Change
5th Dec 20232:10 pmRNSBlock listing Interim Review
4th Dec 202311:15 amRNSTotal Voting Rights and Capital
16th Nov 20236:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20232:56 pmRNSHolding(s) in Company
2nd Nov 202312:44 pmRNSDirector/PDMR Shareholding
31st Oct 20233:00 pmRNSTotal Voting Rights
30th Oct 20233:45 pmRNSDirector/PDMR Shareholding
26th Oct 20237:00 amBUSHalf-year Report
16th Oct 20235:16 pmRNSDirector/PDMR Shareholding
6th Oct 202312:30 pmRNSHolding(s) in Company
27th Sep 20233:56 pmRNSHolding(s) in Company
19th Sep 20237:00 amBUSStatement re FY2024 H1 pre-close Trading Statement
15th Sep 20232:10 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSDirectorate Changes
18th Aug 20239:35 amRNSDirector Declaration
16th Aug 20234:15 pmRNSDirector/PDMR Shareholding
20th Jul 20239:00 amRNSDirector Declaration
17th Jul 20233:15 pmRNSDirector/PDMR Shareholding
13th Jul 20231:00 pmRNSResult of AGM
13th Jul 20237:00 amBUSAGM Statement
6th Jul 20234:00 pmRNSHolding(s) in Company
3rd Jul 20235:45 pmRNSHolding(s) in Company
26th Jun 202312:06 pmRNSHolding(s) in Company
16th Jun 20232:00 pmRNSDirector/PDMR Shareholding
14th Jun 20236:05 pmRNSDirector/PDMR Shareholding
14th Jun 20238:30 amRNSAnnual Report & Notice of AGM
13th Jun 20234:30 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSBlock listing Interim Review
30th May 20237:00 amRNSHolding(s) in Company
26th May 202312:15 pmRNSDirector/PDMR Shareholding
24th May 20231:45 pmRNSDirector/PDMR Shareholding
24th May 202312:00 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amBUSFinal Results
19th May 20237:00 amBUSStatement re Trading Update & Directorate Changes
16th May 20232:00 pmRNSDirector/PDMR Shareholding
4th May 20231:30 pmRNSHolding(s) in Company
17th Apr 20233:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amBUSPre-close Trading Statement
16th Mar 20233:15 pmRNSDirector/PDMR Shareholding
15th Mar 20232:00 pmRNSHolding(s) in Company
23rd Feb 202311:00 amRNSHolding(s) in Company
15th Feb 20234:15 pmRNSDirector/PDMR Shareholding
10th Feb 20232:19 pmBUSStatement re Directorate Changes and Board Committee Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.